Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
Background The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown to reduce renal fibrosis induced by transforming growth factor-beta1. The aim of this...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Korean Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aa71d2dc0dc64f388810ccd4f18dfbc4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:aa71d2dc0dc64f388810ccd4f18dfbc4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:aa71d2dc0dc64f388810ccd4f18dfbc42021-12-01T05:07:51ZSulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-72233-60792233-608710.4093/dmj.2020.0168https://doaj.org/article/aa71d2dc0dc64f388810ccd4f18dfbc42021-11-01T00:00:00Zhttp://www.e-dmj.org/upload/pdf/dmj-2020-0168.pdfhttps://doaj.org/toc/2233-6079https://doaj.org/toc/2233-6087Background The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown to reduce renal fibrosis induced by transforming growth factor-beta1. The aim of this study was to investigate the epigenetic effect of SFN on BMP-7 expression in diabetes-induced renal fibrosis. Methods Streptozotocin (STZ)-induced diabetic mice and age-matched controls were subcutaneously injected with SFN or vehicle for 4 months to measure the in vivo effects of SFN on the kidneys. The human renal proximal tubular (HK11) cell line was used to mimic diabetic conditions in vitro. HK11 cells were transfected to over-express HDAC2 and treated with high glucose/palmitate (HG/Pal) to explore the epigenetic modulation of BMP-7 in SFN-mediated protection against HG/Pal-induced renal fibrosis. Results SFN significantly attenuated diabetes-induced renal fibrosis in vivo. Among all of the HDACs we detected, HDAC2 activity was markedly elevated in the STZ-induced diabetic kidneys and HG/Pal-treated HK11 cells. SFN inhibited the diabetes-induced increase in HDAC2 activity which was associated with histone acetylation and transcriptional activation of the BMP-7 promoter. HDAC2 over-expression reduced BMP-7 expression and abolished the SFN-mediated protection against HG/Pal-induced fibrosis in vitro. Conclusion Our study demonstrates that the HDAC inhibitor SFN protects against diabetes-induced renal fibrosis through epigenetic up-regulation of BMP-7.Lili KongHongyue WangChenhao LiHuiyan ChengYan CuiLi LiuYing ZhaoKorean Diabetes Associationarticlebone morphogenetic protein 7diabetic nephropathieshistone deacetylase 2sulforafanDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENDiabetes & Metabolism Journal, Vol 45, Iss 6, Pp 909-920 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
bone morphogenetic protein 7 diabetic nephropathies histone deacetylase 2 sulforafan Diseases of the endocrine glands. Clinical endocrinology RC648-665 |
spellingShingle |
bone morphogenetic protein 7 diabetic nephropathies histone deacetylase 2 sulforafan Diseases of the endocrine glands. Clinical endocrinology RC648-665 Lili Kong Hongyue Wang Chenhao Li Huiyan Cheng Yan Cui Li Liu Ying Zhao Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7 |
description |
Background The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown to reduce renal fibrosis induced by transforming growth factor-beta1. The aim of this study was to investigate the epigenetic effect of SFN on BMP-7 expression in diabetes-induced renal fibrosis. Methods Streptozotocin (STZ)-induced diabetic mice and age-matched controls were subcutaneously injected with SFN or vehicle for 4 months to measure the in vivo effects of SFN on the kidneys. The human renal proximal tubular (HK11) cell line was used to mimic diabetic conditions in vitro. HK11 cells were transfected to over-express HDAC2 and treated with high glucose/palmitate (HG/Pal) to explore the epigenetic modulation of BMP-7 in SFN-mediated protection against HG/Pal-induced renal fibrosis. Results SFN significantly attenuated diabetes-induced renal fibrosis in vivo. Among all of the HDACs we detected, HDAC2 activity was markedly elevated in the STZ-induced diabetic kidneys and HG/Pal-treated HK11 cells. SFN inhibited the diabetes-induced increase in HDAC2 activity which was associated with histone acetylation and transcriptional activation of the BMP-7 promoter. HDAC2 over-expression reduced BMP-7 expression and abolished the SFN-mediated protection against HG/Pal-induced fibrosis in vitro. Conclusion Our study demonstrates that the HDAC inhibitor SFN protects against diabetes-induced renal fibrosis through epigenetic up-regulation of BMP-7. |
format |
article |
author |
Lili Kong Hongyue Wang Chenhao Li Huiyan Cheng Yan Cui Li Liu Ying Zhao |
author_facet |
Lili Kong Hongyue Wang Chenhao Li Huiyan Cheng Yan Cui Li Liu Ying Zhao |
author_sort |
Lili Kong |
title |
Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7 |
title_short |
Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7 |
title_full |
Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7 |
title_fullStr |
Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7 |
title_full_unstemmed |
Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7 |
title_sort |
sulforaphane ameliorates diabetes-induced renal fibrosis through epigenetic up-regulation of bmp-7 |
publisher |
Korean Diabetes Association |
publishDate |
2021 |
url |
https://doaj.org/article/aa71d2dc0dc64f388810ccd4f18dfbc4 |
work_keys_str_mv |
AT lilikong sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7 AT hongyuewang sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7 AT chenhaoli sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7 AT huiyancheng sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7 AT yancui sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7 AT liliu sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7 AT yingzhao sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7 |
_version_ |
1718405563801403392 |